Literature DB >> 12636142

Sentinel cases of community-acquired methicillin-resistant Staphylococcus aureus onboard a naval ship.

James E LaMar1, Russell B Carr, Craig Zinderman, Kimberly McDonald.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is emerging as a community-acquired organism. A number of recent reports have documented its involvement in a variety of infections in which no risk factors for nosocomial transmission are present. This report presents the initial cases of a MRSA outbreak on a U.S. Navy ship. Each patient failed traditional antibiotic therapy and one required hospitalization. Their presentations evolved simultaneously and proved to be sentinel cases of an outbreak of cutaneous MRSA infections. The events of this outbreak emphasize the growing need to consider the prevalence of resistant organisms in outpatient settings, as well as the impact that infections from resistant organisms might have on the combat readiness of a military unit. Recommendations addressing infection-control guidelines for MRSA within close-quarter environments of healthy adults, such as military units, need to be developed and existing infection-control measures need to be regularly emphasized.

Entities:  

Mesh:

Year:  2003        PMID: 12636142

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  12 in total

Review 1.  [Community-based MRSA. A new challenge for dermatology].

Authors:  W Witte; M Wiese-Posselt; U Jappe
Journal:  Hautarzt       Date:  2005-08       Impact factor: 0.751

Review 2.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 3.  Development of a vaccine against Staphylococcus aureus.

Authors:  Brad Spellberg; Robert Daum
Journal:  Semin Immunopathol       Date:  2011-11-14       Impact factor: 9.623

4.  Community-associated methicillin-resistant Staphylococcus aureus: trends in case and isolate characteristics from six years of prospective surveillance.

Authors:  Kathryn Como-Sabetti; Kathleen H Harriman; Jessica M Buck; Anita Glennen; David J Boxrud; Ruth Lynfield
Journal:  Public Health Rep       Date:  2009 May-Jun       Impact factor: 2.792

Review 5.  Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus.

Authors:  Jason E Farley
Journal:  J Am Acad Nurse Pract       Date:  2008-02

6.  Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial.

Authors:  Michael W Ellis; Matthew E Griffith; David P Dooley; Joseph C McLean; James H Jorgensen; Jan E Patterson; Kepler A Davis; Joshua S Hawley; Jason A Regules; Robert G Rivard; Paula J Gray; Julia M Ceremuga; Mary A Dejoseph; Duane R Hospenthal
Journal:  Antimicrob Agents Chemother       Date:  2007-08-06       Impact factor: 5.191

7.  Community-associated methicillin-resistant Staphylococcus aureus, Minnesota, 2000-2003.

Authors:  Jessica M Buck; Kathryn Como-Sabetti; Kathleen H Harriman; Richard N Danila; David J Boxrud; Anita Glennen; Ruth Lynfield
Journal:  Emerg Infect Dis       Date:  2005-10       Impact factor: 6.883

8.  The human nasal microbiota and Staphylococcus aureus carriage.

Authors:  Daniel N Frank; Leah M Feazel; Mary T Bessesen; Connie S Price; Edward N Janoff; Norman R Pace
Journal:  PLoS One       Date:  2010-05-17       Impact factor: 3.240

9.  Shift in Staphylococcus aureus clone linked to an infected tattoo.

Authors:  Mary E Stemper; Jennifer M Brady; Salah S Qutaishat; Gwen Borlaug; James Reed; Kurt D Reed; Sanjay K Shukla
Journal:  Emerg Infect Dis       Date:  2006-09       Impact factor: 6.883

10.  Community-acquired methicillin-resistant Staphylococcus aureus among military recruits.

Authors:  Craig E Zinderman; Byron Conner; Mark A Malakooti; James E LaMar; Adam Armstrong; Bruce K Bohnker
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.